Not available
Quote | Chembio Diagnostics Inc. (NASDAQ:CEMI)
Last: | $0.455 |
---|---|
Change Percent: | 1.65% |
Open: | $0.4475 |
Close: | $0.455 |
High: | $0.455 |
Low: | $0.447 |
Volume: | 351,642 |
Last Trade Date Time: | 04/27/2023 03:00:00 am |
News | Chembio Diagnostics Inc. (NASDAQ:CEMI)
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...
Message Board Posts | Chembio Diagnostics Inc. (NASDAQ:CEMI)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CEMI News Article - Biosynex Extends Tender Offer for the shares of Chembio Diagnostic | whytestocks | investorshangout | 03/15/2023 12:00:46 PM |
Chembio Diagnostics: SEC Admin. Proceeding; | Renee | investorshub | 03/03/2023 2:38:02 PM |
Does the company that is buying chembio trade | 2248 | investorshub | 02/02/2023 8:55:29 PM |
whytestocks: $CEMI News Article - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATCX, CEM | whytestocks | investorshangout | 02/01/2023 3:15:46 PM |
whytestocks: $CEMI News Article - CEMI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sa | whytestocks | investorshangout | 02/01/2023 3:10:46 PM |
Chembio Diagnostics Inc. Company Name:
CEMI Stock Symbol:
NASDAQ Market:
Chembio Diagnostics Inc. Website:
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVI...
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...